Literature
首页医源资料库在线期刊美国临床营养学杂志2005年82卷第4期

High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort

来源:《美国临床营养学杂志》
摘要:s,Sweden(LB)2SupportedbygrantsfromtheSwedishCancerFoundationandtheSwedishResearchCouncil–。ABSTRACTBackground:High-fatdairyfoodscontainmanypotentiallyanticarcinogenicfactors,includingconjugatedlinoleicacid(CLA)。However,fewepidemiologicstudieshavespecificall......

点击显示 收起

Susanna C Larsson, Leif Bergkvist and Alicja Wolk

1 From the Division of Nutritional Epidemiology, the National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (SCL and AW), and the Department of Surgery and Centre for Clinical Research, Central Hospital, Västerås, Sweden (LB)

2 Supported by grants from the Swedish Cancer Foundation and the Swedish Research Council–Longitudinal Studies (STINT).

3 Reprints not available. Address correspondence to SC Larsson, Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, SE-171 77 Stockholm, Sweden. E-mail: susanna.larsson{at}imm.ki.se.


ABSTRACT  
Background: High-fat dairy foods contain many potentially anticarcinogenic factors, including conjugated linoleic acid (CLA). However, few epidemiologic studies have specifically evaluated high-fat dairy food consumption, and none have evaluated CLA intake, in relation to colorectal cancer risk.

Objective: The aim of this study was to prospectively examine the associations of long-term high-fat dairy food consumption and CLA intake and the incidence of colorectal cancer.

Design: Our study population consisted of 60 708 women aged 40–76 y who participated in the Swedish Mammography Cohort. The women’s consumption of high-fat dairy foods was assessed at baseline, which was from 1987 to 1990, and again in 1997.

Results: We ascertained 798 incident cases of colorectal cancer during an average 14.8 y of follow-up. After adjustment for age and other potential confounders, the women who consumed 4 servings of high-fat dairy foods/d (including whole milk, full-fat cultured milk, cheese, cream, sour cream, and butter) had a multivariate rate ratio of colorectal cancer of 0.59 (95% CI: 0.44, 0.79; P for trend = 0.002) when compared with the women who consumed <1 serving/d. Each increment of 2 servings of high-fat dairy foods/d corresponded to a 13% reduction in the risk of colorectal cancer (multivariate rate ratio: 0.87; 95% CI: 0.78, 0.96). For CLA, the multivariate rate ratio of colorectal cancer in a comparison of the 2 extreme quartiles of intake was 0.71 (95% CI: 0.55, 0.91; P for trend = 0.004).

Conclusion: These prospective data suggest that high intakes of high-fat dairy foods and CLA may reduce the risk of colorectal cancer.

Key Words: Colorectal cancer, • cohort studies, • conjugated linoleic acid, • dairy foods, • epidemiology


INTRODUCTION  
Dairy foods are a rich source of many potentially anticarcinogenic factors that may play a role in the prevention of colorectal cancer. Indeed, a high consumption of milk and total dairy foods has been associated with a lowered risk of colorectal cancer in several prospective cohort studies (1, 2). Of all the components of dairy foods, calcium has attracted the most attention. Findings from the Pooling Project of Prospective Studies of Diet and Cancer (1), which was based on 10 cohort studies, showed that an inverse association between total milk consumption and the risk of colorectal cancer was attenuated but remained significant after controls for calcium, which suggests that other milk components may confer additional protection. Dairy foods, particularly high-fat dairy foods, are the principal source of not only calcium but also conjugated linoleic acid (CLA) (3), which is a potent anticarcinogen in animal models (4-7). However, to our knowledge, no study has examined the role of CLA in the development of colorectal cancer in humans. Furthermore, epidemiologic studies that specifically investigated the association between high-fat dairy food consumption and the risk of colorectal cancer are sparse and the results are inconsistent (8-11). Although one case-control study (10) observed a nonsignificant inverse association between the consumption of high-fat dairy foods and the risk of colon cancer, the results of 2 other case-control studies (9, 11) and one cohort study of mortality from colon cancer (8) were largely null. In those study populations, however, the consumption of high-fat dairy foods may have been too low to provide a protective effect against colorectal cancer.

The consumption of high-fat dairy foods is relatively high in the Swedish population. We decided, therefore, to prospectively examine the association between long-term consumption of high-fat dairy foods (measured at 2 time points) and the incidence of colorectal cancer, overall and by subsite, in a population-based cohort of Swedish women. We also evaluated whether CLA intake is associated with colorectal cancer risk.


SUBJECTS AND METHODS  
The Swedish Mammography Cohort
The Swedish Mammography Cohort was established between 1987 and 1990, when all women who were aged 40–76 y and who resided in the Uppsala and Västmanland counties of central Sweden received a mailed questionnaire, which contained questions on diet, weight, height, and educational level (12). Of the 90 303 eligible women, 66 651 (74%) completed the questionnaire. Exposure data were updated in 1997. The Ethics Committees of the Uppsala University Hospital and the Karolinska Institutet (Stockholm, Sweden) approved the study.

Dietary assessment
At baseline (1987–1990), diet was assessed with the use of a 67-item food-frequency questionnaire (FFQ). An expanded FFQ that included 96 items was used to update the information about diet in 1997. In these questionnaires, the participants were asked how often, on average, they had consumed each food or beverage over the past year; 8 predefined frequency categories were available. We also inquired about the types of fat and oil used for food preparation and at meals, and we inquired about the number of sandwiches consumed daily that contained fat and the usual fat layer on these sandwiches (thick, thin, very thin, or no fat). The FFQs included open-ended questions for some commonly consumed foods, such as milk, yogurt, and cheese. Nutrient intakes were calculated as the frequency of consumption multiplied by the nutrient content of age-specific (<53, 53–65, 66 y) portion sizes, with the use of composition values from the Swedish Food Administration Database (13). CLA intake was estimated according to published data on the concentrations of CLA found in the total fat of various foods (14, 15). We adjusted all nutrient values for total energy intake using the residual method (16). Total high-fat dairy food consumption was computed by adding the daily servings of whole milk (3% fat), full-fat (3% fat) cultured milk (mainly sour milk), cheese (mainly hard cheese, 28% fat), cream (40% fat), full-fat sour cream (34% fat), reduced-fat sour cream (17% fat), and butter (80% fat). Information on cream and sour cream consumption was first obtained in the 1997 FFQ. Total low-fat dairy food consumption was computed by adding the daily servings of low-fat milk (0.5% fat), medium-fat milk (1.5% fat), and low-fat cultured milk (0.5% fat).

In a study of the validity of the FFQ that was conducted in 129 women who were randomly chosen from the cohort, Spearman correlation coefficients (r) between the mean intake, which was assessed from four 1-wk diet records, and the FFQ ranged from 0.33 (for whole milk) to 0.64 (for low-fat milk) for dairy foods ( = 0.50). As estimated from the FFQ, the intake of pentadecanoic acid (15:0), which is a marker for dairy fat intake, also correlated with both the pentadecanoic acid intake that was estimated from diet records (r = 0.63) and the percentage of this fatty acid in adipose tissue (r = 0.40) ( Population for the analysis
Of the 66 651 women enrolled in the cohort, we excluded those with an erroneous national registration number, those with missing dates on the questionnaire, those with a cancer diagnosis (except nonmelanoma skin cancer), those who reported implausible intakes for total energy (ie, 3 SDs from the loge-transformed mean energy intake in the study population), and those with missing responses to all high-fat dairy foods. This left 60 708 women for the analysis.

Ascertainment of cases and follow-up
Passive follow-up of the participants was conducted by linkages to the Swedish Cancer, Total Population, and Death Registers through 30 June 2004. The Swedish Cancer Registry has been documented to be close to 100% complete (18). Tumors located from the cecum through the splenic flexure were considered to be proximal colon cancers, and tumors in the descending and sigmoid colon were defined as distal colon cancers. Rectal cancers included tumors in the rectosigmoid junction and the rectum.

Statistical analysis
Person-time of follow-up for each woman was accumulated from the date of entry into the cohort until the date of a colorectal cancer diagnosis, death from any cause, date of moving away from the study area, or 30 June 2004, whichever came first. We grouped women into categories according to their dairy food consumption. For each category, we calculated the incidence rate of colorectal cancer by dividing the number of cases by the number of person-years of follow-up and computed the rate ratios for each of the upper categories by dividing the rates in these categories by the rate in the lowest category.

To represent long-term diet, we applied a cumulative average method (19) using dietary data from the baseline and 1997 questionnaires. In this analysis, colorectal cancer incidence from 1987 through 1997 was related to the dietary intake that was assessed by the baseline questionnaire, and incidence from 1998 through June 2004 was related to the average intake that was reported at baseline and in 1997.

We estimated rate ratios (RRs) with 95% CIs using Cox proportional hazards modeling (20) stratified by age (in mo) at recruitment and the year of entry into the cohort. All multivariate models had controls for age, body mass index, education, and intakes of total energy, folate, vitamin B-6, cereal fiber, and red meat. Using data from the 1997 questionnaire, we conducted additional analyses that were adjusted for smoking, physical activity, family history of colorectal cancer, and use of multivitamins, aspirin, oral contraceptives, and postmenopausal hormones. We also examined whether associations with high-fat dairy foods could be attributed to calcium and vitamin D by adding these nutrients to the multivariate model. Tests for trend were performed by assigning the median consumption of high-fat dairy foods for categories treated as a continuous variable. We also used restricted cubic spline Cox proportional hazards regression models with 4 knots (21) to flexibly model the association between high-fat dairy food consumption and the risk of colorectal cancer. Differences in the results in colorectal cancer subsites (proximal colon, distal colon, and rectum) were tested with the Wald test (22). All analyses were conducted with SAS version 9.1 (SAS Institute Inc, Cary, NC). All P values are 2-sided.

We performed secondary analyses to examine the association of CLA intake with colorectal cancer risk using baseline diet data (values for CLA were not available for the 1997 questionnaire). In addition to the variables that were included in the multivariate analyses of high-fat dairy food consumption, all multivariate analyses of CLA intake were also adjusted for calcium and vitamin D intakes.


RESULTS  
During a mean 14.8 y of follow-up, 798 incident cases of colorectal cancer were diagnosed in the 60 708 eligible women. Of these cancers, 543 were located in the colon (246 proximal, 170 distal, and 127 unknown subsite) and 249 in the rectum; 6 cases of both colon and rectal cancer were diagnosed. The baseline characteristics of the study population according to their consumption of high-fat dairy foods are shown in Table 1. At baseline, cheese was the largest source of high-fat dairy foods consumed and constituted 49% of the total servings; butter, whole milk, and full-fat cultured yogurt constituted 26%, 13%, and 12%, respectively. Compared with women who consumed low amounts of high-fat dairy food, the women who had higher consumption were younger, leaner, and more likely to have a postsecondary education; they also had higher intakes of red meat and calcium but lower intakes of folate, vitamin B-6, vitamin D, and cereal fiber.


View this table:
TABLE 1. Baseline characteristics of the study population according to frequency of total high-fat dairy food consumption1

 
Total high-fat dairy food consumption was significantly and inversely associated with the risk of colorectal cancer (Table 2). Compared with the women who consumed <1 serving of high-fat dairy foods/d, the women who consumed 4 servings/d had a multivariate RR of 0.59 (95% CI: 0.44, 0.79). Additional adjustments for alcohol consumption, family history of colorectal cancer, smoking, physical activity, and the use of multivitamin supplements, aspirin, oral contraceptives, and postmenopausal hormones did not signficantly change the results. Also, these findings remained after addition of calcium and vitamin D intakes to the multivariate model (RR: 0.58; 95% CI: 0.42, 0.79). After exclusion of cancer cases that occurred during the first 3 y of follow-up, the multivariate RR of colorectal cancer was 0.57 (95% CI: 0.40, 0.81). Results of analyses that used only the baseline diet were similar to those obtained with the use of the average cumulative diet (multivariate RR: 0.64; 95% CI: 0.48, 0.85). The reduction in the risk of cancer that was associated with high consumption of high-fat dairy foods was most pronounced for the incidence of cancer of the distal colon (Table 2). A test for the difference in associations by cancer site was statistically significant (P for heterogeneity = 0.04 in a comparison of the highest categories).


View this table:
TABLE 2. Rate ratios (RRs) of colorectal cancer by long-term high-fat dairy food consumption

 
A spline regression analysis showed a dose-response relation between high-fat dairy food consumption and the risk of colorectal cancer (Figure 1). The multivariate RR for a daily increase in consumption of 2 servings of high-fat dairy foods was 0.87 (95% CI: 0.78, 0.96) for colorectal cancer and 0.66 (95% CI: 0.52, 0.84) for distal colon cancer.


View larger version (15K):
FIGURE 1.. Multivariate rate ratios of colorectal cancer by long-term high-fat dairy food consumption. Data were fitted with the use of a restricted cubic spline Cox proportional hazards model. Multivariate rate ratios were adjusted for age (in mo), body mass index (in kg/m2; <23, 23–24.9, 25–29.9, and 30), education (less than high school, high school graduate, or more than high school), total energy intake (continuous), and quintiles of intakes of folate, vitamin B-6, cereal fiber, and red meat. The dotted lines represent 95% CIs.

 
We next examined the association between the individual high-fat dairy food items and the risk of colorectal cancer (Table 3). The lowest risk of colorectal cancer was observed for high consumption of cheese. In a multivariate model, we observed a 35% (95% CI: 4%, 56%) reduction in the risk of colorectal cancer in the women who consumed 3 servings of cheese/d compared with the women who consumed <1 serving/d. High consumption of butter and full-fat cultured milk also showed significant inverse associations with the risk of colorectal cancer. We observed no association between low-fat dairy food consumption and the risk of colorectal cancer. Compared with the lowest category of consumption (never or seldom), the multivariate RRs for increasing categories of total low-fat dairy food consumption (<1.0, 1.0 to <2.0, 2.0 to <3.0, and 3.0 servings/d) were 1.09, 1.09, 1.03, and 1.06, respectively (95% CI: 0.72, 1.54).


View this table:
TABLE 3. Multivariate rate ratios (RRs) of colorectal cancer by long-term high-fat dairy food consumption1

 
CLA intake was significantly and inversely related to colorectal cancer risk (Table 4). The multivariate RR for women in the highest quartile of CLA intake compared with those in the lowest quartile was 0.71 (95% CI: 0.56, 0.91). Similar to the observation for high-fat dairy foods, this reduction in risk was largely due to a strong association with cancer of the distal colon.


View this table:
TABLE 4. Rate ratios (RRs) of colorectal cancer by quartiles of conjugated linoleic acid intake

 
To assess whether the observed inverse relation between high-fat dairy food consumption and colorectal cancer could be attributed to CLA, we simultaneously entered baseline intakes of high-fat dairy foods and CLA (r = 0.70) in a multivariate model. The inverse association between high-fat dairy food consumption and the risk of colorectal cancer was somewhat attenuated (RR for the highest compared with the lowest category: 0.75; 95% CI: 0.49, 1.14). In this model, the multivariate RR in a comparison of the 2 extreme quartiles of CLA intake was 0.81 (95% CI: 0.57, 1.15).


DISCUSSION  
We observed a significant inverse association between long-term consumption of high-fat dairy foods and the risk of colorectal cancer, particularly of cancer of the distal colon, in this large population-based cohort of women who had repeated diet assessments. For each daily increment of 2 servings of high-fat dairy foods, the risk of colorectal cancer decreased by 13% and the risk of distal colon cancer decreased by 34%. The reduction in colorectal cancer risk associated with high consumption of high-fat dairy foods was not explained by other potential risk factors for colorectal cancer and persisted after control for calcium and vitamin D intakes.

Components in high-fat dairy foods that might reduce the risk of colorectal cancer include CLA, sphingomyelin, and ether lipids (23). Although these components have been shown to inhibit colorectal carcinogenesis in animal models (4-7, 23-26), to our knowledge no published epidemiologic data exist on the relation between these compounds and the risk of colorectal cancer in humans. CLA is a collective term for a group of positional and geometric isomers of linoleic acid that have various biological effects. Although cis-9, trans-11-CLA is the predominant isomer (80–90%) in dairy foods, it is found in equal proportions with the trans-10, cis-12-CLA isomer in commercial preparations of CLA (27). Recent studies that used specific CLA forms indicate that the 2 isomers can have different effects on metabolism and cell functions and can act through different cell signaling pathways (27). A small number of studies have also raised the concern that supplementation with the trans-10, cis-12-CLA isomer might have adverse effects on insulin sensitivity, on biomarkers of oxidative stress and inflammation, and on the blood lipid profile in humans (28-30).

In the present study, we examined whether the observed inverse association between high-fat dairy food consumption and the risk of colorectal cancer could be explained by CLA. The inverse relation remained but was no longer significant after control for CLA intake, which indicated that the observed protective effect of high-fat dairy foods may only be partly attributable to CLA intake. Hence, other components in high-fat dairy foods, possibly sphingomyelin and ether lipids, may contribute to additional protection from colorectal cancer.

Studies in animals have shown that dietary CLA significantly reduces carcinogen-induced mutagenesis in the distal colon but not in the proximal colon (31, 32). In agreement with these experimental findings, we observed that the reduction in cancer risk with high intakes of high-fat dairy foods and CLA was most pronounced for the incidence of distal colon cancer. Multiple lines of evidence indicate that proximal and distal colon cancers may have different causes (33, 34), and it has been postulated that exogenous factors, such as diet, are more related to tumors in the distal colon (33).

Of the high-fat dairy foods that were assessed in this analysis, the strongest inverse association was observed for cheese, which is the single largest contributor of dairy fat in the cohort. Findings of previous studies on the relation between cheese consumption and colorectal cancer risk have mostly been null. In a meta-analysis of 10 case-control and 4 cohort studies, the overall RR of colorectal cancer was 1.07 (95% CI: 0.92, 1.25) when the top and bottom categories of cheese consumption were compared (2). The Pooling Project of Prospective Studies of Diet and Cancer (1) also observed no association between cheese consumption and colorectal cancer risk. A possible explanation for the null results in previous studies might be that the consumption of cheese in the populations studied was too low for a protective effect. The findings of the present study suggest that 3 servings of cheese/d (60 g/d or more) are needed for a reduction in the risk of colorectal cancer. The mean cheese consumption in the Swedish Mammography Cohort is about twice that of most of the other cohort studies in the Pooling Project (1); the cutoff value for the highest category of cheese consumption in the Pooling Project was 25 g/d (1).

Our study has several important strengths, which include its large size, the large number of colorectal cancer cases, and its population-based and prospective design. The completeness of follow-up of the study population minimized the likelihood that our findings were affected by bias because of differential follow-up of exposed compared with unexposed women. Because information about dietary intake was collected before the colorectal cancer diagnosis, any error in the measurement of high-fat dairy food consumption would have attenuated rather than exaggerated a true association. We had repeated measures of dietary intake and were able to examine both baseline and cumulative updated diet values. Cumulative updating of diet intakes can reduce random within-person measurement error and can better reflect long-term dietary intake.

As in any observational study, we cannot rule out the possibility that some unmeasured factor or residual confounding factor accounted for the observed associations. In the present study, higher consumption of high-fat dairy foods was associated with lower intakes of folate, vitamin B-6, and cereal fiber and with higher red meat consumption. The confounding effects of these variables would tend to bias the results toward a positive, not an inverse, association. Indeed, findings from multivariate analyses that were adjusted for these dietary factors showed associations that were somewhat stronger than those in the age-adjusted analyses.

Besides CLA, high-fat dairy foods are a source of saturated fat. Although ecologic studies have implicated high intake of saturated fat as a risk factor for coronary heart disease (35), most large prospective cohort studies have not found significant positive associations between intakes of saturated fat (36-38) or high-fat dairy foods (39) and the risk of coronary heart disease. However, more research on the relation between CLA and high-fat dairy foods and the risk of colorectal cancer and other health outcomes is needed to evaluate the potential risks and benefits of increasing intakes of high-fat dairy foods.

In conclusion, our findings from a large population-based cohort of women with repeated diet assessments suggest that high consumption of high-fat dairy foods may lower the risk of colorectal cancer, particularly of cancer of the distal colon. The observed inverse association might, in part, be related to CLA intake, but other potentially anticarcinogenic components in high-fat dairy foods cannot be excluded. Our observational study cannot prove a cause-effect relation, and it is premature to recommend increased consumption of high-fat dairy foods. Because of the potential public health implications of these findings, more studies of the relation between the risk of colorectal cancer and CLA and high-fat dairy food intakes are warranted. Additional work is also needed to elucidate the mechanisms underlying the ability of dietary fat to protect against colorectal cancer.


ACKNOWLEDGMENTS  
SCL and AW contributed to the study concept and design. LB and AW contributed to the data collection and interpretation of the results. SCL contributed to the data analyses, writing of the manuscript, and interpretation of the results. All authors reviewed the final manuscript. None of the authors had any financial or personal conflicts of interest.


REFERENCES  

  1. Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004;96:1015-22.
  2. Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 2003;57:1-17.
  3. Parodi PW. Cows’ milk fat components as potential anticarcinogenic agents. J Nutr 1997;127:1055-60.
  4. Park HS, Ryu JH, Ha YL, Park JH. Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 2001;86:549-55.
  5. Kim KH, Park HS. Dietary supplementation of conjugated linoleic acid reduces colon tumor incidence in DMH-treated rats by increasing apoptosis with modulation of biomarkers. Nutrition 2003;19:772-7.
  6. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 1995;16:3037-43.
  7. Park HS, Cho HY, Ha YL, Park JH. Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem 2004;15:229-35.
  8. Thun MJ, Calle EE, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 1992;84:1491-500.
  9. Iscovich JM, L’Abbe KA, Castelleto R, et al. Colon cancer in Argentina. I: Risk from intake of dietary items. Int J Cancer 1992;51:851-7.
  10. Shannon J, White E, Shattuck AL, Potter JD. Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:495-502.
  11. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000;11:459-66.
  12. Wolk A, Bergstrom R, Hunter D, et al. A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med 1998;158:41-5.
  13. Bergström L, Kylberg E, Hagman U, Erikson H, Bruce Å. The food composition database KOST: the National Administration’s information system for nutritive values of food. Vår Föda 1991;43:439-47.
  14. Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Comp Anal 1992;5:185-97.
  15. Jiang J, Björck L, Fondén R. Conjugated linoleic acid in Swedish dairy products with special reference to manufacturing of hard cheeses. Int Dairy J 1997;7:863-7.
  16. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
  17. Wolk A, Vessby B, Ljung H, Barrefors P. Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 1998;68:291-5.
  18. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
  19. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-40.
  20. Cox DR, Oakes D. Analysis of survival data. London, United Kingdom: Chapman and Hall, 1984.
  21. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
  22. Greenland S, Rothman KJ. Introduction to stratified analysis. In: Rothman KJ, Greenland S, eds. Modern epidemiology. Philadelphia, PA: Lippincott-Raven, 1998:253-79.
  23. Molkentin J. Occurrence and biochemical characteristics of natural bioactive substances in bovine milk lipids. Br J Nutr 2000;84(suppl):S47-53.
  24. Dillehay DL, Webb SK, Schmelz EM, Merrill AH Jr. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 1994;124:615-20.
  25. Schmelz EM, Dillehay DL, Webb SK, Reiter A, Adams J, Merrill AH Jr. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 1996;56:4936-41.
  26. Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz EM. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 2003;419:129-38.
  27. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 2004;43:553-87.
  28. Tricon S, Burdge GC, Kew S, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 2004;80:614-20.
  29. Riserus U, Smedman A, Basu S, Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004;79(suppl):1146S-8.
  30. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002;106:1925-9.
  31. Yang H, Glickman BW, de Boer JG. Effect of conjugated linoleic acid on the formation of spontaneous and PhIP-induced mutation in the colon and cecum of rats. Mutat Res 2002;500:157-68.
  32. Yang H, Stuart GR, Glickman BW, de Boer JG. Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr Cancer 2001;39:259-66.
  33. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-88.
  34. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
  35. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, MA: Harvard University Press, 1980.
  36. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997;145:876-87.
  37. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996;313:84-90.
  38. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses’ Health Study. Am J Epidemiol 2005;161:672-9.
  39. Hu FB, Stampfer MJ, Manson JE, et al. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 1999;70:1001-8.
Received for publication April 12, 2005. Accepted for publication June 29, 2005.


作者: Susanna C Larsson
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具